毛头鬼伞的本草考证及不良反应研究进展

doi:10.19803/j.1672-8629.20240052

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (5): 502-506.
DOI: 10.19803/j.1672-8629.20240052

• 药用真菌资源开发与安全应用专栏（一） • 上一篇下一篇

毛头鬼伞的本草考证及不良反应研究进展

高海云^1,2,陈瑜鑫^1,2,李瑶^1,2,李慧^1,2,刘天睿^1,2,3#,袁媛^1,2,4*

¹中国中医科学院中医药健康产业研究所，中药资源可持续利用江西省重点实验室，江西南昌 330115;
²江西中医药健康产业研究院，江西南昌 330115;
³昭通学院，云南省天麻与真菌共生生物学重点实验室，云南昭通 657099;
⁴中国中医科学院中药资源中心，道地药材品质保障与资源持续利用全国重点实验室，北京 100700

收稿日期:2024-01-25 出版日期:2024-05-15 发布日期:2024-05-13
通讯作者: ^*袁媛,女,博士,研究员·博导,中药鉴定与分子生药学。E-mail：y_yuan0732@163.com ^#为共同通信作者。
作者简介:高海云,女,硕士,研究实习员,中药资源与分子生药学。
基金资助:
中央级公益性科研院所基本科研业务费专项（ZZ16-ND-12、ZZ16-XRZ-105）; 中国中医科学院科技创新工程重大攻关项目（CI2021B014、CI2023D001/CI2023E002-04）; 中央本级重大增减支项目（2060302）; 江西省“双千计划”项目（TMKF2023B01）; 国家杰出青年科学基金（82325049）

Herbal textual research and adverse reaction study of Coprinus comatus

GAO Haiyun^1,2, CHEN Yuxin^1,2, LI Yao^1,2, LI Hui^1,2, LIU Tianrui^1,2,3#, YUAN Yuan^1,2,4,*

¹Key Laboratory of Sustainable Utilization of Traditional Chinese Medicine Resources in Jiangxi Province, Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang Jiangxi 330115, China;
²Jiangxi Health Industry Institute of Traditional Chinese Medicine, Nanchang Jiangxi 330115, China;
³Yunnan Key Laboratory of Gastrodia and Fungi Symbiotic Biology, Zhaotong University, Zhaotong Yunnan 657099, China;
⁴State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica China Academy of Chinese Medical Sciences, Beijing 100700, China

Received:2024-01-25 Online:2024-05-15 Published:2024-05-13

摘要/Abstract

摘要： 目的探究药用真菌毛头鬼伞的用药历史与现代研究进展,为毛头鬼伞进一步研究应用提供参考。方法查阅古代本草专著,对毛头鬼伞的名称、产地、形态、药性、功效进行考证,并结合现代文献研究进行深入探索。结果毛头鬼伞用药历史悠久,其古代名称为鬼盖、地盖、鬼屋等,现代称毛头鬼伞、鸡腿菇。性平、味甘,归胃、心经,主治小儿寒热惊痫证、疔疮肿毒、恶疮、蜈蚣蛇蝎伤。现代药理学研究表明毛头鬼伞具有抗氧化、抗癌、保护肝脏、抗炎、抗糖尿病、抗菌、抗病毒和抗线虫活性等药理作用。通过系统查阅古今文献发现,毛头鬼伞可能引起双硫仑样反应、胃肠炎型中毒、特应性皮炎患者的皮肤反应、富集重金属等不良反应。结论通过对毛头鬼伞的本草考证及不良反应进行总结,可为毛头鬼伞的安全利用提供依据。

关键词: 毛头鬼伞, 鸡腿菇, 本草考证, 双硫仑样反应, 药用安全, 不良反应

Abstract: Objective Exploring the medication history and modern research progress of the medicinal fungus Coprinus comatus, providing reference for further research and application of C. comatus. Methods By consulting ancient herbal monographs, we conducted research on the name, origin, morphology, medicinal properties, and efficacy of C. comatus, and conducted in-depth exploration in combination with modern literature research. Results C. comatus has a long history of being used in medicine. The ancient names of C. comatus were Gui Gai, Di Gai, Gui Wu. C. comatus and shaggy mane were the modern names of C. comatus. C. comatus was sweet in properties, flat in tastes, and distributed to stomach and heart meridian tropisms. It is used in the treatment of children's cold and feverish epilepsy, boils and swollen poisons, malignant sores, and centipede, snake and scorpion injuries. Modern pharmacological studies had shown that C. comatus had pharmacological effects such as antioxidant, anticancer, hepatoprotective, anti-inflammatory, antidiabetic, antimicrobial, antiviral, and antinematode activity. Through a systematic review of ancient and modern literature, it was found that C. comatus may cause adverse reactions such as disulfiram-like reaction, gastroenteritis-type poisoning, skin reactions in atopic dermatitis patients, and heavy metal enrichment. Conclusion This article provides a basis for the safe utilization of C. comatus by summarizing the herbal research and adverse reactions of C. comatus.

Key words: Coprinus comatus, Shaggy mane, herbal textual research, disulfiram-like reaction, pharmaceutical security, adverse reaction

中图分类号:

高海云,陈瑜鑫,李瑶,李慧,刘天睿,袁媛. 毛头鬼伞的本草考证及不良反应研究进展[J]. 中国药物警戒, 2024, 21(5): 502-506.

GAO Haiyun, CHEN Yuxin, LI Yao, LI Hui, LIU Tianrui, YUAN Yuan. Herbal textual research and adverse reaction study of Coprinus comatus[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 502-506.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.zgywjj.com/CN/10.19803/j.1672-8629.20240052

https://www.zgywjj.com/CN/Y2024/V21/I5/502

参考文献

[1] QIU H, DONG Y, LIU C, et al.Effects of Coprinus comatus (chicken drumstick mushroom) on the quality characteristics of low nitrite-backfat Cantonese sausages[J]. LWT, 2023, 187: 115339.
[2] ZHENG Z, QU H, ZHOU H, et al.Changes in quality, ultrastructure, reactive oxygen species and cell wall metabolisms of postharvest Coprinus comatus stored at different temperatures[J]. Scientia Horticulturae, 2022, 298: 110989.
[3] CAO XL, CHEN Y, PENG WH, et al.Genetic diversity analysis and comprehensive evaluation of agronomic traits of Coprinus comatus germplasm resources[J]. Acta Edulis Fungi(食用菌学报), 2022, 29(5): 53-64.
[4] GAO Z.Characterization and mechanism on renovating diabetic nephropathic of mycelia polysaccharides from Coprinus comatus[D]. Jinan: Shandong Agricultural University, 2022.
[5] GAO Z, KONG D, CAI W, et al.Characterization and anti-diabetic nephropathic ability of mycelium polysaccharides from Coprinus comatus[J]. Carbohydrate Polymers, 2021, 251: 117081.
[6] TAO HJ.Ming Yi Bie Lu(名医别录)[M]. Beijing: People's Medical Publishing House, 1986.
[7] LI SZ.Compendium of Materia Medica(本草纲目)[M]. Beijing: Huaxia Press, 2004.
[8] LIU WT.Collected Essentials of Species of Material Medical(本草品汇精要)[M]. Beijing: Huaxia Press, 2004.
[9] SU J.Newly Revised Materia Medica(新修本草)[M]. Hefei: Anhui Science and Technology Press, 2004.
[10] TAO HJ.Collective Notes to Canon of Materia Medica(本草经集注)Collated edition[M]. Beijing: People's medical publishing house, 1994.
[11] TANG SW. Classified Material Medical(证类本草)[M]. Beijing: China Medical Science and Technology Press, 2011.
[12] MAO XL.Overview of the classification of medicinal fungi[J]. Edible Fungi(食用菌), 1983, 5(4): 48-49.
[13] CHEN XY.Lentinus edodes, Agaricus campestris, Guigai explanation[J]. Agricultural Archaeology(农业考古), 1993, 13(1): 166-167.
[14] PAN ZH, NIE FQ.Broad spectrum bacteria[J]. Edible Fungi of China(中国食用菌), 1991, 10(1): 43-44.
[15] CHEN ZQ.A Supplement to Materia Medica(本草拾遗)[M]. Hefei: Anhui Science and Technology Press, 2002.
[16] WU QJ.Textual Research on Reality and Titles of Plants(植物名实图考长编)[M]. Beijing: The Commercial Press, 1959.
[17] LI LF.Day and night-Guisan and Guibi[J]. Knowledge Is Power(知识就是力量), 2023, 78(8): 34-35.
[18] WANG T.Arcane Essentials from the Imperial Library(外台秘要方)[M]. Beijing: China Medical Science and Technology Press, 2011.
[19] FENG MF.Notes on ancient veterinary native herbs[J].Information on Veterinary Science and Technology(兽医科技资料), 1976, 6(2): 81-90.
[20] LIU BZ. Chinese Medicinal Fungi(中国药用真菌)[M]. Taiyuan: Shanxi People's Publishing House, 1974.
[21] HUANG B, XIAN J.Textual research on the materia medica of Guiwei[J]. Journal of Chinese Medicine(中医杂志), 1989, 35(8): 58
[22] CAO XL, GU YF, CHEN Y, et al.Identification and evaluation of a wild strain of Coprinus comatus[J]. Chinese Edible Fungi(中国食用菌), 2022, 41(5): 10-14, 22.
[23] PATRYK N, SYLWIA KN, RENATA M, et al.The two faces of Coprinus comatus-functional properties and potential hazards[J]. Phytotherapy Research: PTR, 2020, 34(11): 2932-2944.
[24] GB/T 12728–2006B/T 12728–2006. Edible mushroom terms(食用菌术语)[S]. Beijing: Standards Press of China, 2006.
[25] MAO YL, JIANG D.Analysis on the names of important edible fungi in China[J]. Edible and Medicinal Fungi(食药用菌), 2012, 20(4): 195-201.
[26] LIU B.Wild edible mushrooms in China[J]. Bulletin of Biology(生物学通报),1963, 12(4): 5-8.
[27] LI Y, BAO HY.Mycomedicines in China(中国菌物药)[M]. Zhengzhou: Zhongyuan People's Publishing House, 2020: 443-448.
[28] YANG ZL.Common Edible and Poisonous Mushrooms of Southwestern China(中国西南地区常见食用菌和毒菌)[M]. Beijing: Science Press, 2021.
[29] SUN SM.Qian Jin Yi Fang(千金翼方)[M]. Beijing: China Medical Science Press, 2011.
[30] LI J, LI XR.Pu Ji Fang Zhu Lu(普济方注录)[M]. Harbin: Heilongjiang Science and Technology Press, 1996.
[31] LI YB.Zuo Yi Zi Zhen(作邑自箴)[M]. Shanghai: Shanghai Ancient Books Publishing House, 1995.
[32] WANG HY.Tai Ping Sheng Hui Fang(太平圣惠方)[M]. Beijing: People's Medical Publishing House, 1958.
[33] WEI W, SUN M, YU JY, et al.Relationship between components, intestinal microbiota, and mechanism of hypoglycemic effect of the saggy ink cap medicinal mushroom (Coprinus comatus, agaricomycetes): a review[J]. International Journal of Medicinal Mushrooms, 2023, 25(12): 81-90.
[34] FAJAR H, HERNAYANTI H, NURAENI E, et al.Antidiabetic effects and antioxidant properties of the saggy ink cap medicinal mushroom, Coprinus comatus (agaricomycetes), in streptozotocin-induced hyperglycemic rats[J]. International Journal of Medicinal Mushrooms, 2021, 23(10): 9-21.
[35] GU DY, TANG SS, LIU C, et al. Optimization of liquid fermentation conditions for Coprinus comatus to enhance antioxidant activity[J]. Preparative Biochemistry Biotechnology, (2023-11-26)[2024-04-19].https://kns.cnki.net/kcms2/article/abstract?v=IILC1c-FiAE5zC1Q7lNCnKhEZ3pM3fwkWaY6YnKm8sNPKpLUR6_L4LcmSLR2B7WKazoOZT3zeeOpcXwbk_3m0ReObRD3OaE9ZDxUcmdX2bSjLxrshIzEovYCCYsoepNucUGKsfSfbn16_i25wYFhUcDiFnCintGkj2fhL3bxmSA=&uniplatform=NZKPT&language=CHS.
[36] PATRYK N, RENATA M, KRYSTYNA G, et al.Mushrooms as potential therapeutic agents in the treatment of cancer: evaluation of anti-glioma effects of Coprinus comatus, Cantharellus cibarius, Lycoperdon perlatum and Lactarius deliciosus extracts[J]. Biomedicine Pharmacotherapy, 2021, 133: 111090.
[37] LI WD, WANG YX, SUN M, et al.The saggy ink cap medicinal mushroom, Coprinus comatus (agaricomycetes), protein attenuates acute alcoholic liver injury in association with changes in the gut microbiota of mice[J]. International Journal of Medicinal Mushrooms, 2021, 23(5): 91-100.
[38] YU JY, SUN JG, SUN M, et al.Protective mechanism of Coprinus comatus polysaccharide on acute alcoholic liver injury in mice, the metabolomics and gut microbiota investigation[J]. Food Science and Human Wellness, 2024, 13(1): 401-413.
[39] QIN Q, TIAN EJ, BAO HY.Classification and structural formula of mushroom toxins[J]. Microbial Research(菌物研究), 2022, 20(2): 128-140.
[40] CHU JZ, CUI Q, YANG SD, et al.Research progress on the toxic mechanism of mushroom toxins[J]. Chinese Herbal Medicine(中草药), 2022, 53(24): 7925-7932.
[41] QIN Q.Study on the toxicity and mechanism of disulfiram like reactions in several types of phantophora fungi[D]. Changchun: Jilin Agricultural University, 2022.
[42] LIN ZQ, CHEN TT, FU XY.Research progress on cephalosporin induced disulfiram like reactions[J]. Strait Pharmacy(海峡药学), 2020, 32(5): 83-85.
[43] QIN Q, BAO HY, YAN F, et al.The toxicity and renal injury mechanism of disulfiram like reaction induced by Coprinus comatus[J]. Acta Edulis Fungi(食用菌学报), 2021, 28(6): 98-108.
[44] BAU T, BAO HY, LI Y.Checklist of poisonous mushrooms in China[J]. Mycosystema(菌物学报), 2014, 33(3): 517-548.
[45] WANG SY.Based on transcriptome sequencing, mining genes related to autolysis in Coprinus comatus[D]. Shenyang: Shenyang Agricultural University, 2020.
[46] CHEN ZH, YANG ZL, TU LGE, et al.Poisonous Mushrooms: Recognition and Poisoning Treatment(毒蘑菇识别与中毒防治)[M]. Beijing: Science Press, 2016.
[47] TANG L, LI SJ, YANG HJ, et al.Autolysis process of neutron body and Related enzyme activity changes in mushroom cultivation[J]. Microbial research(菌物研究), 2021, 19(3): 184-190.
[48] WEI JJ, WANG ZG, ZHANG HR, et al.Research on the nutritional composition and preservation processing of chicken leg mushroom[J]. Chinese Fruit and Vegetable Journal(中国果菜), 2020, 40(6): 77-82.
[49] BO HG, FEI ZZ, QING JW, et al.Transcriptome analysis of genes associated with autolysis of Coprinus comatus[J]. Scientific Reports, 2022, 12(1): 2476.
[50] HAI LY, ZHI HZ, HUA BZ, et al.Proteomics reveals the mechanism underlying the autolysis of postharvest Coprinus comatus fruiting bodies[J]. Journal of Agricultural and Food Chemistry, 2022, 70(4): 1346-1357.
[51] XIN XF, YAN JZ, TIAN F, et al.Cultivation techniques of Coprinus comatus[J]. South China Agriculture(南方农业), 2021, 15(32): 43-44, 47.
[52] CHA LJ, ZHOU DD, FENG HJ, et al.Research on the bioaccumulation characteristics of two kinds of wild edible fungi to soil heavy metals[J]. Ecology and Environmental Sciences(生态环境学报), 2021, 30(10): 2093-2099.
[53] LI YL, ZHANG XM, ZHANG B, et al.Research on the application of clinical drug-oriented risk assessment method for harmful components of traditional Chinese medicine[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(5): 475-480.
[54] JERZY F.Mercury bio-extraction by fungus Coprinus comatus: a possible bioindicator and mycoremediator of polluted soils?[J]. Environmental Science and Pollution Research International, 2016, 23(8): 7444-7451.
[55] CEN F, HU Y, XU H.Responses of antioxidant defenses in Coprinus comatus exposed to cadmium and mercury toxicity[J]. Asian Journal of Chemistry, 2012, 24(10): 4679-4685.
[56] REN J, SHI JL, HAN CC, et al.Isolation and biological activity of triglycerides of the fermented mushroom of Coprinus comatus[J]. BMC Complementary and Alternative Medicine, 2012,12(52): 1-5.
[57] ZHAO HJ, LI HP, LAI QQ, et al.Antioxidant and hepatoprotective activities of modified polysaccharides from Coprinus comatus in mice with alcohol-induced liver injury[J]. International Journal of Biological Macromolecules, 2019, 15(127): 476-485.
[58] HUANG DM, LI HL, ZHANG ZC.Safety test of Coprinus comatus fermentation broth[J]. Food Technology(食品科技), 2009, 34(3): 107-110, 114.

毛头鬼伞的本草考证及不良反应研究进展

Herbal textual research and adverse reaction study of Coprinus comatus

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	刘天睿, 李瑶, 陈瑜鑫, 李慧, 高海云, 袁媛. 7种常见易发生不良反应真菌的毒性分析及安全应用[J]. 中国药物警戒, 2024, 21(5): 489-495.
[2]	于静, 帕拉提·热合曼, 赵婷, 冯继荣, 孙岩, 何磊. 拉考沙胺治疗4岁以下癫痫患儿疗效、安全性与血药浓度的相关性研究[J]. 中国药物警戒, 2024, 21(5): 559-562.
[3]	刘翠丽, 吴晨, 王涛. 吡拉西坦制剂安全性风险分析及思考[J]. 中国药物警戒, 2024, 21(5): 563-566.
[4]	武一,何金阳,王晓剑,周效竹,刘冉佳,郭明星,赵莹,代文迪,崔向丽. 基于美国VAERS数据库的肝、肾移植受者接种新型冠状病毒疫苗不良事件分析[J]. 中国药物警戒, 2024, 21(5): 572-579.
[5]	苏小涵, 曾姣, 李雪, 刘礼鑫, 侯令密, 李金穗. 基于美国FAERS数据库的乳腺癌患者使用阿贝西利不良事件分析[J]. 中国药物警戒, 2024, 21(5): 580-586.
[6]	杨波, 王梦娇, 胡丽丽, 王来成, 李倩, 孔飞飞, 吕冬梅, 沈佳妮. 385例PD-1抗肿瘤治疗的安全性研究及风险因素分析[J]. 中国药物警戒, 2024, 21(4): 447-450.
[7]	黎海燕, 杨忠旭, 刘跃昆, 王丽虹. 1例甲氨蝶呤治疗异位妊娠致严重不良反应患者的药学监护[J]. 中国药物警戒, 2024, 21(4): 454-456.
[8]	李少强, 孔旭东, 李朋梅. 注射用奥美拉唑钠致低钠血症1例分析[J]. 中国药物警戒, 2024, 21(4): 461-463.
[9]	伍诗琪, 闫素英, 张青霞. 艾多沙班药代动力学相互作用研究进展[J]. 中国药物警戒, 2024, 21(4): 473-480.
[10]	黄焕均, 麦嘉恒, 张云惠, 郭晨晨, 梁蔚婷. 613例抗肿瘤药物的不良反应分析[J]. 中国药物警戒, 2024, 21(3): 324-328.
[11]	刘琦, 张玉凤, 罗皓, 李歆. 106例安罗替尼临床应用的合理性与安全性分析[J]. 中国药物警戒, 2024, 21(3): 329-334.
[12]	吉秋霞, 金剑, 章斌. 特瑞普利单抗免疫相关不良事件药学监护[J]. 中国药物警戒, 2024, 21(3): 346-348.
[13]	陈杰, 张斌, 赵俊, 张传洲. 托珠单抗注射液致过敏性休克1例分析[J]. 中国药物警戒, 2024, 21(3): 349-351.
[14]	杨雪婷, 何波, 闫鸿丽, 李冬梅. 克拉霉素致急性短暂性抑郁症不良反应1例分析[J]. 中国药物警戒, 2024, 21(3): 352-354.
[15]	王常顺, 王晓蕾, 段吉平, 袁浩, 刘永利, 赵丁. 硫磺熏蒸对白芷质量的影响及产地替代加工方式探讨[J]. 中国药物警戒, 2024, 21(3): 355-360.